CountryDE, ES, FR, IT
CallJTC 2014


Clinical utility of tumour heterogeneity in triple negative breast cancer and high-grade serous ovarian carcinoma for prediction of therapy response

Project Coordinator

  • Manfred DIETEL
    • Institute of Pathology, Charité University Hospital
    • Berlin - Germany

Project Partners 

  • Violeta SERRA
    • Vall d' Hebron Institute of Oncology, Experimental Therapeutics Group
    • Barcelona - Spain
  • Giuseppe VIALE
    • European Institute of Oncology, Department of Pathology
    • Milan - Italy
  • Alexandra LEARY
    • Institut Gustave Roussy Gynecology Unit, Translational Research Laboratory INSERM U981
    • Villejuif - France